share_log

CVS Health | 424B3: Prospectus

CVS Health | 424B3: Prospectus

西维斯健康 | 424B3:募资说明书
美股SEC公告 ·  2024/12/03 21:21

Moomoo AI 已提取核心信息

On December 3, 2024, CVS Health announced an offering of Fixed-to-Fixed Rate Series A and B Junior Subordinated Notes, maturing in 2055 and 2054, respectively. The Series A Notes will bear interest from the issuance date to 2030, and the Series B Notes to 2034, with rates reset based on the Five-year U.S. Treasury Rate plus a spread.CVS Health may defer interest payments for up to 10 years, with deferred interest accruing additional interest. The notes are unsecured and subordinated to senior indebtedness, with no established trading market. Proceeds will be used for tender offers and general corporate purposes.The offering is not conditioned on the tender offers' completion. Settlement is expected in December 2024, with delivery through The Depository Trust Company. The notes involve certain risks, including subordination to senior debt and potential interest deferral.
On December 3, 2024, CVS Health announced an offering of Fixed-to-Fixed Rate Series A and B Junior Subordinated Notes, maturing in 2055 and 2054, respectively. The Series A Notes will bear interest from the issuance date to 2030, and the Series B Notes to 2034, with rates reset based on the Five-year U.S. Treasury Rate plus a spread.CVS Health may defer interest payments for up to 10 years, with deferred interest accruing additional interest. The notes are unsecured and subordinated to senior indebtedness, with no established trading market. Proceeds will be used for tender offers and general corporate purposes.The offering is not conditioned on the tender offers' completion. Settlement is expected in December 2024, with delivery through The Depository Trust Company. The notes involve certain risks, including subordination to senior debt and potential interest deferral.
2024年12月3日,CVS Health宣布发行固定利率A系列和b系列初级次级票据,分别于2055年和2054年到期。A系列票据将从发行之日起计息至2030年,b系列票据将从发行之日起计息至2034年,利率将根据五年期美国国债利率加上利差进行重置。CVS Health最多可以将利息支付推迟10年,递延利息应计额外利息。这些票据是无抵押的,从属于优先债务,没有成熟的交易市场。所得款项将用于要约和一般公司用途。此次发行不以投标要约的完成为条件。预计将在2024年12月达成和解,并通过存托信托公司交付。这些票据涉及某些风险,包括优先债务的附属权和潜在的延期利息。
2024年12月3日,CVS Health宣布发行固定利率A系列和b系列初级次级票据,分别于2055年和2054年到期。A系列票据将从发行之日起计息至2030年,b系列票据将从发行之日起计息至2034年,利率将根据五年期美国国债利率加上利差进行重置。CVS Health最多可以将利息支付推迟10年,递延利息应计额外利息。这些票据是无抵押的,从属于优先债务,没有成熟的交易市场。所得款项将用于要约和一般公司用途。此次发行不以投标要约的完成为条件。预计将在2024年12月达成和解,并通过存托信托公司交付。这些票据涉及某些风险,包括优先债务的附属权和潜在的延期利息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息